MedTrace Logo

Efficacy of Metformin in Preventing Diabetes in China

NCT03441750 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1724

Last updated 2021-11-15

No results posted yet for this study

Summary

A multicentred, randomized, open study to evaluate the efficacy of metformin in preventing Diabetes.

Conditions

Interventions

DRUG

metformin

Metformin tablets will be administrated in the experimental arm.

OTHER

Standard lifestyle intervention

Standard lifestyle advice will be united for all subjects by providing special booklet. * All participants will receive 20-30 minutes individual or group session with assigned nurse addressing the harm of prediabetes and the importance of a healthy lifestyle for preventing Diabetes. * The amount of energy intake of the participants will be calculated based on the ideal body weight and physical activity levels. The sample recipe will be explained by the nurse and provided in the diet instruction. * Moderate intensity physical activity (150 minutes per week) is recommended. * Smoking cessation is encouraged for the smoker. * Excessive alcohol intake is encouraged to avoid.

Sponsors & Collaborators

  • Chinese Association of Geriatric Research

    lead OTHER

Principal Investigators

  • Guangwei Li, M.D., Ph.D. · Chinese Association of Geriatric Research

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-25
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03441750 on ClinicalTrials.gov